Medtronic announces FDA approval and U.S. launch of next generation pacemakers
Medtronic announced FDA approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with BlueSync(TM)technology. Available in both single chamber and dual chamber models, the Azure XT MRI and Azure S MRI pacemakers offer improved longevity, estimated at 13.7 years. November 20, 2017